Merchavia Holdings and Investments Ltd (TLV:MRHL)
Israel · Delayed Price · Currency is ILS · Price in ILA 80.90
0.00 (0.00%)
Aug 4, 2025, 3:16 PM IDT
Nuvei Revenue
In the year 2024, Merchavia Holdings and Investments had annual revenue of 119.00K ILS, down -93.56%. Merchavia Holdings and Investments had revenue of -4.61M in the half year ending December 31, 2024, with 202.83% growth.
Revenue
119.00K
Revenue Growth
-93.56%
P/S Ratio
142.77
Revenue / Employee
119.00K
Employees
1
Market Cap
16.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 119.00K | -1.73M | -93.56% |
| Dec 31, 2023 | 1.85M | -2.31M | -55.59% |
| Dec 31, 2022 | 4.16M | -6.45M | -60.78% |
| Dec 31, 2021 | 10.61M | 3.18M | 42.86% |
| Dec 31, 2020 | 7.43M | 122.00K | 1.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.81B |
| Kamada | 622.70M |
| Bait Bakfar | 104.50M |
| SofWave Medical | 235.09M |
| BrainsWay | 161.81M |
| Novolog (Pharm-Up 1966) | 2.07B |
| Ilex Medical | 922.08M |